Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-operative Diclofenac Potassium for IANB Efficacy in Pulpitis
NCT03163420Phase 3Unknown
- Sponsor
- Cairo University
- Start
- Jul 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in irreversible pulpitis comparing Diclofenac potassium with Placebo (2 arms). Primary endpoint: Anesthetic success during root canal treatment. Status: unknown.
02
Drugs
diclofenac
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT03163420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03163420.